Business
CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine – The Motley Fool Australia
Australian global biotech giant, CSL Limited didn’t win the sprint for a coronavirus vaccine. But it may lead the marathon.
The CSL Limited(ASX: CSL) share price is edging higher today, up 0.2% in afternoon trading.
That’s broadly in line with the wider S&P/ASX 200 Index (ASX: XJO), up 0.4% at time of writing.
With a history of generally delivering fairly steady share price growth, 2020 has been unusually volatile for CSL shareholders. While there are various reasons for this, traders jumping in and out of shares based on the latest COVID-19 vaccine news have certainly helped stir this year’s share price volatility.
…
-
Business24 hours ago5 things to watch on the ASX 200 on Monday 1 September 2025
-
Noosa News24 hours agoStar Brisbane cricketer finds home in suburb with shocking popularity rise
-
Noosa News11 hours agoMassive wind farm project in Queensland axed amid community backlash
-
Business15 hours agoIAG shares are racing higher today. Here’s why